United States · Investor

MDS Capital

No cheque observed since Jun 2007, after 16 earlier cheques, and the website is parked.

DormantGrowth equity

Series CSeries ASeries B

Cheques on record
0%of best year0cheques in 12 months, 16 on record
Since the last cheque7061days00hrs00min00sec
Median round$31MRounds led0 of 16Exits7 from the portfolioMostly inUnited States, 81%
Pitch MDS Capital

MDS Capital highlights

  1. 01

    16 rounds on record

  2. 02

    Mostly Series C and Series A: 56% of its rounds

  3. 03

    7 exits from the portfolio

What they do

Type
Growth equity (from a list, unverified)
Cheque size
Not stated
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first16 appearances

  1. 2007

    3 rounds

  2. Jun
    U-SystemsSeries E · US$17MWith 7 others
  3. Feb
    MAKO SurgicalSeries C · US$30MWith 5 others
  4. Jan
    Ception TherapeuticsSeries C · US · ceptiontx.com$63MWith 4 others
  5. 2006

    2 rounds

  6. Sept
    RenaMed BiologicsVenture · US · venturecapitalreporter.com$40MWith 8 others
  7. May
    KAI PharmaceuticalsSeries B · US · kaipharmaceuticals.com$35MWith 6 others
  8. 2005

    1 round

  9. Nov
    Adnavance TechnologiesSeries A · US · biospace.com$3.9MWith 2 others
  10. 2004

    6 rounds

  11. Dec
    Inimex PharmaceuticalsSeries A · CA$1.7MWith 4 others
  12. Nov
    ViOptixSeries C · US$9.2MWith 3 others
  13. Jul
    AlveolusSeries B · US$10MWith 4 others
  14. Apr
    Corus PharmaSeries C · US$60MWith 16 others
  15. Apr
    ArchemixSeries B · US$50MWith 8 others
  16. Mar
    TransMolecularSeries C · US$33MWith 11 others
  17. 2003

    2 rounds

  18. Nov
    Neuromed PharmaceuticalsSeries C · CA$32MWith 5 others
  19. Feb
    Twinstrand TherapeuticsVenture · CA$6.7MWith 3 others
  20. 2002

    2 rounds

  21. Dec
    TriVirix InternationalSeries D · US$25MWith 11 others
  22. Aug
    ArchemixSeries A · US$52MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 1 person at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Exits from the portfolio

Companies it backed that were later bought or listed7 in all

MAKO SurgicalBought by Stryker Corporation$1.6BSept 2013
U-SystemsBought by GE HealthcareUndisclosedNov 2012
KAI PharmaceuticalsBought by Amgen$315MApr 2012
Ception TherapeuticsBought by Cephalon$250MFeb 2010
Neuromed PharmaceuticalsBought by ZalicusUndisclosedDec 2009
Twinstrand TherapeuticsBought by CangeneUndisclosedJul 2009
Corus PharmaBought by Gilead SciencesUndisclosedOct 2006

An exit counts when it came after the firm's first round in the company. From historical deal records.

Who they invest alongside

The investors most often in the same rounds as MDS Capital. A count of rooms they were both in, not a relationship either has claimed.

GrowthWorksVC firm4rounds togetherAperture Venture PartnersVC firm3rounds togetherBDC CapitalVC firm3rounds togetherPOSCO BioVenturesVC firm3rounds togetherAtlas VentureVC firm2rounds togetherCare CapitalGrowth equity2rounds togetherCogene VenturesVC firm2rounds togetherMB Venture PartnersVC firm2rounds togetherProspect Venture PartnersVC firm2rounds togetherTSC BioVenture Capital CorporationVC firm2rounds togetherTVM CapitalPrivate equity2rounds togetherUS Trust Private EquitGrowth equity2rounds together

Quick answers about MDS Capital

What does MDS Capital invest in?

MDS Capital invests most often at Series C and Series A (56% of the rounds on record).

How active is MDS Capital?

16 investments on record, 0 of them in the last 12 months. The most recent was in Jun 2007.

How big are MDS Capital's cheques?

The median round it joins is $31M.

Does MDS Capital lead rounds?

Rarely, if at all: none of its 16 investments on record names it as the lead.

Where does MDS Capital invest?

Most of the companies it backs are in the United States (81%) and Canada (19%).

Is MDS Capital investing now?

It looks quiet: no investment on record since Jun 2007.

Who does MDS Capital invest alongside?

Most often GrowthWorks (4 rounds together), Aperture Venture Partners (3 rounds together) and BDC Capital (3 rounds together).

What kind of investor is MDS Capital?

MDS Capital is a growth equity firm based in United States.

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it